Accueil

WELBIO is an inter-university life sciences research institute based in Wallonia, Belgium. WELBIO is funded by the Walloon Region. Our mission is to support strategic fundamental research through carefully selected projects from universities in the Wallonia-Brussels Federation, with a view to transforming their discoveries into industrial applications in all fields of biotechnology.

NEWS
A better understanding of embryonic development
27/05/2020

In a study published in Nature, Isabelle Migeotte (WELBIO 2015-2019 - ULB) and her colleagues clarify a key stage of embryonic development. This data is essential for improving the production of synthetic embryos and limit the use of animal embryos.


Type 1 diabetes: how interferon-α impacts human pancreatic β-cells.
25/05/2020

In a recent paper published in Nature Communications, Decio L. Eizirik (WELBIO investigator at ULB) and colleagues used a multi-omics approach to clarify the impact of interferon-α on human beta cells.


Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
20/05/2020

In a recent review paper published in Nature Reviews Endocrinology. Decio L. Eizirik (WELBIO investigator at ULB) and colleagues discuss the mechanisms leading to pancreatic beta cell failure in diabetes.


All news


Last update : 20/4/2018 - Vie privée - Printable version -  © 2020 WELBIO

Home Login